Tiamat Sciences

About:

Tiamat Sciences makes plant-based growth factors & proteins for cell-culture

Website: https://www.tiamat-sciences.com/

Top Investors: True Ventures, Social Impact Capital, Siddhi Capital, Cantos, Portfolia

Description:

Tiamat is a start-up producing affordable animal-free growth factors and biomolecules using plants as bioreactors. Thanks to its propriety platform, the company can manufacture a wide range of high-value proteins from antigens to growth factors. The company has already achieved a 10x cost reduction and at scale can get costs down 1000x even at 80% growth-margins, giving them a wide ability to price strategically. the coming years. The low investment needed to build a facility (up to 40x less than current solutions) combined with its unique technology makes Tiamat the ideal partner in production scale-up for promising markets that will soon become enormous such as cellular agriculture or cell & gene therapy.

Total Funding Amount:

$5.54M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Durham, North Carolina, United States

Founded Date:

2019-09-01

Contact Email:

contact(AT)tiamat-sciences.com

Founders:

Clément Carlier, France-Emmanuelle Adil

Number of Employees:

1-10

Last Funding Date:

2023-03-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai